ISPOR 2018 SCIENTIFIC AWARDS WINNERS

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 10%, based on abstract review score, are considered and eligible for a poster presentation award. 
Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation

THE RECIPIENTS ARE: . . .

ISPOR Best Podium Research Presentation Awards

Best General Podium Presentations

Ashley Jaska

HT4 - Health Technology Assessment (HTA) Agencies Consideration of Real World Evidence (RWE)

Erin Arthurs

AV3 - Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults living with HIV-1 : A Canadian Cost Utility Analysis

Lou P. Garrison

VA3 - “It's Tough to Make Predictions, Especially About the Future”: Comparing Life Expectancy Predictions Based on Period Versus Cohort Life Tables 

Best Student Podium Research Presentations

Xue Han

CV2 - Secondary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis 

Xiaohan Hu

VA2 - Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S.

Franscesco Saverio Mennini

VA4 - Economic Consequences of Anti-HCV Antiviral Treatment Investment From the NHS Perspective 

Best New Investigator Podium Research Presentations

Nicolae Done

CV3 - Comparative Effectiveness of Direct Oral anticoagulants Versus Warfarin in Patients with Atrial Fibrillation

J. A. Voelker

HU1 - Annual Change in Controlled Substance Opioid Prescribing and Concomitant Medications from an Urban Academic Emergency Department from 2011- 2016

Christopher G. Fawsitt

AV2 - Cost-Effectiveness analysis of Baseline Testing for Resistance-associated Polymorphisms to Optimize Treatment Duration in Genotype 1 Non-Cirrhotic Treatment-Naive Patients with Chronic Hepatitis C. Virus

ISPOR Best Poster Research Presentation Awards

Best General Poster Research Presentations

Andrzei Orlowski

PUK20 - Comparison of Costs Associated with Turp and Prostatic Urethral Lift for Benign Prostatic Hyperplasia

Ellen R. Thiel

PCV61 - Inpatient Admission Length of Stay and Costs among Vascular Procedure Patients Receiving Perclose Proglide Suture-Mediated Closure Compared to Patients Receiving Surgical Cutdown for Closure of Large Bore Atrerial Access

Peter Classi

PSY107 - Treatment with Prostacyclins Delays and Reduces Hospital Readmissions Among PAH Patients

Best Student Poster Research Presentations

Hrishikesh P. Kale

PCN212 - Economic Burden of Renal Cell Carvcnoma Among Older Adults in the Targeted Therapy Era

Hyeun Ah Kang

PSY63 - Association Between Hydroxyurea Medication Adherence and Vaso-Occlusive Crisis Events Among Texas Medicaid Enrollees with Sickle Cell Disease

Ghadeer Dawwas

PCV20 - Comparative Effectiveness of apixaban Versus Warfarin for the Prevention of Recurrent Venous Thromboembolism and Cardiovascular Diseases in Patients with Venous Thromboembolism

Best New Investigator Poster Research Presentations

Elmor D. Pineda

PMS9 - Predictors and Incidence of Cardiovascular Events in Patients with Rheumatoid Arthritis

Dante M. Grassi

PND8 - Real World Outcomes and Medication Adherence to Disease Modifying Therapies (DMTS) Among Patients with Multiple Sclerosis (MS)

Saurabh P. Nagar

PRS41 - Prescription Opioid Use Among Children and Adolescents with Asthma in the United States: National Estimates from 2011 to 2015

 

ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster research presentations.